Early research (Phase 1)Study completedNCT00260702
What this trial is testing
Omalizumab to Treat Hyper-IgE (Job's) Syndrome
Who this might be right for
Hyper-IgE SyndromeJob's Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 1